Content Details
Information on this page was last modified on : 2024/06/10 7:48:19 PM

Brukinsa (Zanubrutinib) 80mg 120 Capsule

Belongs to Category

How It Works

Zanubrutinib, the active ingredient in Brukinsa, works by binding to and inhibiting Bruton’s tyrosine kinase (BTK), an enzyme that plays a crucial role in the survival and proliferation of B-cells. By inhibiting BTK, Brukinsa disrupts the signaling pathways necessary for the growth and survival of malignant B-cells, thereby slowing the progression of the disease.

Side Effects

  • Neutropenia (low white blood cell count)
  • Upper respiratory tract infection
  • Bruising
  • Rash
  • Anemia (low red blood cell count)
  • Thrombocytopenia (low platelet count)
  • Muscle pain
  • Fatigue

Indications

  • Mantle cell lymphoma (MCL) in patients who have received at least one prior therapy
  • Chronic lymphocytic leukemia (CLL)
  • Waldenström’s macroglobulinemia (WM)

Contraindications

  • Hypersensitivity to zanubrutinib or any of its components
  • Severe hepatic impairment
  • Concomitant use with strong CYP3A inhibitors

Price Comparison in Different Countries

Country Price (per bottle of 120 capsules) Reference
Pakistan Approximately PKR 1,000,000 Dawaai Pakistan
United States USD 12,000 GoodRx
United Kingdom GBP 9,000 NHS UK
Canada CAD 15,000 Health Canada
Australia AUD 18,000 PBS Australia

Top 5 Global Brands

  1. Roche
  2. Novartis
  3. Pfizer
  4. Merck & Co.
  5. Johnson & Johnson

Conclusion

Brukinsa (Zanubrutinib) 80mg is a critical medication for treating specific blood cancers, including mantle cell lymphoma, chronic lymphocytic leukemia, and Waldenström’s macroglobulinemia. By inhibiting the BTK enzyme, it disrupts the growth and survival of malignant B-cells, providing a targeted treatment option for patients. While effective, Brukinsa does come with potential side effects and contraindications that need careful consideration and management. The cost of Brukinsa varies significantly worldwide, highlighting the importance of accessibility and affordability in cancer treatment. Patients should consult their healthcare providers to determine if Brukinsa is suitable for their condition and explore financial assistance options if necessary.

 

Additional Information:

One of the following licensed pharmacy from the nearest location will deliver Brukinsa (Zanubrutinib) 80mg 120 Capsule. The details of the licensed pharmacy shall be shared once you request the drugs and the respective pharmacy accepts your request based on valid prescription and availability.

Want to share this information?
Facebook
Twitter
LinkedIn
Something doesn't feel right ?

Questions and Answers

There are no questions yet. Be the first to ask a question about this product.

Only registered users are eligible to enter questions

Reviews

There are no reviews yet.

Be the first to review “Brukinsa (Zanubrutinib) 80mg 120 Capsule”
Shopping Cart